SH3TC1 Inhibitors

SH3TC1 Inhibitors refer to a diverse group of chemicals chosen based on SH3TC1's potential involvement in protein-protein interactions via its SH3 domains. Such domains are pivotal for several cellular operations like endocytosis, cell signaling, and cytoskeleton modulation. Src Inhibitor 1 and PP1, for instance, target Src family kinases, often associated with SH3 domains. Zoledronic acid, on the other hand, offers insights into any possible role of SH3TC1 in osteoclast function, given that some SH3 domain proteins are involved in bone dynamics.

The emphasis on cytoskeleton dynamics is clear with the inclusion of compounds like Cytochalasin D, Latrunculin A, and Swinholide A. If SH3TC1 plays any part in shaping the cellular structure or movement, these agents provide a window into such functions. Furthermore, by incorporating inhibitors like Dynasore and CK-666, we tap into SH3TC1's possible involvement in endocytic processes and actin branching.